Jonas Oldgren - Researcher Profile | RDL Research Database

Publications

4 shown

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Paulus Kirchhof , Stefano Benussi , Dipak Kotecha +47 more

peer reviewed

2016 European Heart Journal 6326 citations

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Stuart J. Connolly , Michael D. Ezekowitz , Salim Yusuf +17 more

In patients with atrial fibrillation, dabigatran given at a dose of 110 mg was associated with rates of stroke and systemic embolism that were similar to those associated with w...

2009 New England Journal of Medicine 11012 citations

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

Lars Wallentin , Salim Yusuf , Michael D. Ezekowitz +11 more

2010 The Lancet 1003 citations

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

John W. Eikelboom , Lars Wallentin , Stuart J. Connolly +13 more

Background— Dabigatran 150 and 110 mg twice a day and warfarin are effective for stroke prevention in atrial fibrillation. The purpose of this study was to compare their risks o...

2011 Circulation 1071 citations

Frequent Co-Authors

Researcher Info

h-index: 4
Publications: 4
Citations: 19,412
Institution: University of Birmingham

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-9969-3921

Impact Metrics

h-index 4

h-index: Number of publications with at least h citations each.